{"id":"W4241026090","doi":"10.21203/rs.2.21605/v2","title":"Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; Health Sciences Centre; Canadian Partnership Against Cancer; Canadian Agency for Drugs and Technologies in Health; Sunnybrook Health Science Centre; Queen's University; Cancer Care Ontario","funders":"Canadian Institutes of Health Research; Government of Ontario; Canadian Centre for Applied Research in Cancer Control; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Ipilimumab; Medicine; Internal medicine; Cohort; Population; Clinical trial; Oncology; Proportional hazards model; Cancer registry; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001851285,0.0003928688,0.0007141165,0.0008231213,0.001795436,0.001155207,0.001351316,0.0005013907,0.001538918],"category_scores_gemma":[0.003985984,0.0003773955,0.001205621,0.00321651,0.0008958773,0.0003374149,0.0006933655,0.0006919727,0.0001253477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03432926,"about_ca_system_score_gemma":0.02611709,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9815639,"about_ca_topic_score_gemma":0.9849305,"domain_scores_codex":[0.9976235,0.000413376,0.0002209549,0.0005580331,0.0006406191,0.0005434839],"domain_scores_gemma":[0.9947851,0.0004559435,0.002036027,0.0003684759,0.001379133,0.0009752245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003455416,0.00004012133,0.9958407,0.00006905733,0.0003755108,0.00009030572,0.0003003418,0.0001553535,0.0001424835,0.0001180512,0.0008765612,0.001645878],"study_design_scores_gemma":[0.0000976758,0.00008396261,0.9975888,0.00004429023,0.0002131607,0.0000844127,0.0003993228,0.0004812214,0.00005310496,0.00003630614,0.0009030327,0.00001489751],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912606,0.001309539,0.0001785064,0.0003909759,0.00001600886,0.0001019973,0.005708628,0.00000693977,0.001026922],"genre_scores_gemma":[0.9978558,0.0003188218,0.0001377089,0.0001113515,0.00001024036,0.00003216232,0.001276951,0.000003001928,0.000253823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03432926,"threshold_uncertainty_score":0.2490774,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1247541909001992,"score_gpt":0.4402671681884053,"score_spread":0.3155129772882061,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}